The in vitro cytotoxicity of the anti-Her2 ADCs was evaluated using the Her2 expressing HCC-1954, NCI-N87 and MDA-MB-453 tumor cell lines and the MDA-MB-468 cell line, which does not express Her2. Here, ERBB2 is linked to hepatocellular carcinoma.